Tekla Life Financials

Please note that past performance is not an indicator of the future performance of Tekla Life, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

You should never invest in Tekla Life Sciences without having analyzed available financial metrics that contribute to the net asset value (NAV) of the fund. Do not rely on someone else's analysis or guesses about the future performance of Tekla Mutual Fund, because this is throwing your money away. Analyzing the key information contained in Tekla Life's prospectus and an annual reports, can give you an edge over other investors and help to ensure that your investments perform well for you.

Tekla Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tekla Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Beta measures systematic risk based on how returns on Tekla Life Sciences correlated with the market. If Beta is less than 0 Tekla Life generally moves in the opposite direction as compared to the market. If Tekla Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tekla Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tekla Life is generally in the same direction as the market. If Beta > 1 Tekla Life moves generally in the same direction as, but more than the movement of the benchmark.

Health Funds